Companies›Healthcare›Healthcare›Healthcare Services
NSE:YATHARTH

YATHARTH HOSP & TRA C S L

Healthcare › Healthcare Services·NIFTY MICROCAP 250NIFTY SMALLCAP 500NIFTY TOTAL MARKET
₹951.60
at close · 27 Oct 2026
▲ 26.50 (+2.86%)

Latest filings

Next results: Tue, 3 Nov · Financial Results
  1. Board meeting to approve September 2026 quarterly and half-year results · Results
  2. EGM approves share capital hike, preferential issue, and special rights to investor · Board & Shareholder Meetings
  3. Yatharth Hospital EGM clears Advent backed Rasmalai preferential issue · Board & Shareholder Meetings
All filings ↓
Ask Nexa about YATHARTH HOSP & TRA C S L

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Operates a chain of multi-speciality hospitals in Delhi-NCR and Uttar Pradesh providing tertiary and quaternary healthcare, with over 3,200 beds across nine facilities and FY26 revenue of ₹1,207 crore. Three new hospitals commenced operations during FY26 — a 300-bed facility in Delhi's Model Town (July 2025), a 400-bed hospital in Faridabad Sector 20 (September 2025), and a 150-bed Shantived hospital in Agra (February 2026) — and these newer units together contributed ₹753 crore (22% of group revenue) in Q4 FY26. A 250-bed under-construction super-speciality hospital in Gurugram Sector 40 was acquired for ~₹200 crore (₹100 crore upfront plus ₹100 crore finishing capex) and is targeted to be operational by April 2027 with expected ARPOB above ₹50,000. The network recorded FY26 occupancy of around 68% and ARPOB of ₹33,124, while CGHS rate revision from December 2025 is expected to add ~5% to revenue and ~3% to EBITDA. Government payers (CGHS and similar schemes) make up ~35% of revenue, with management targeting a reduction to ~25% over two years by reweighting the payer mix toward the newer hospitals. Management is targeting 5,000 beds within three years — currently over 3,200 — with roughly 70% of additions via acquisitions and 30% greenfield, at ~₹75 lakh per bed for the Noida Extension and Greater Noida brownfield projects. The largest cost line is other operating expenses at 36.9% of revenue, followed by employee costs at 19.4% and depreciation at 7.3%.

Revenue mix · reported segments
Hospital healthcare services100.0%
Government payers (CGHS and similar)35.0%
Newer hospitals (Delhi, Faridabad Sec-20, Agra)22.0%
Operating scale
Bed capacity (current)
Over 3,200 bedsFY26
Hospital count
9 hospitals across NCR and UPFY26
FY26 occupancy
68%FY26
ARPOB
₹33,124Q4 FY26
Gurugram pipeline
250-bed super-speciality hospital; ARPOB >₹50,000 expected; operational by April 2027FY27
Bed expansion target
5,000 beds over next 3 years (~70% acquisition, 30% greenfield)3-year
Who pays it
Patients across Delhi-NCR and Uttar Pradesh, including a significant share served under government schemes (CGHS and similar)
Biggest cost
Other operating expenses at 36.9% of revenue, with employee costs at 19.4% and depreciation at 7.3%
Kind of business
Capital-intensive, regionally clustered multi-speciality hospital chain in North India with active bed-capacity expansion
Where it sits
Delhi-NCR-focused hospital operator running nine facilities in NCR and UP, targeting 5,000 beds within three years
Market Cap
₹9,169 Cr
P / E (TTM)
50.6×
EV / EBITDA
27.1×
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
11.0%·
ROCE (FY26)
ROE 9.4% · margin 26.3%
Leverage
0.14·
Debt / Equity · low
Net debt ₹32 Cr
Revenue FY24→FY26
1.8×▲
Margin −3.0 pts
₹671 Cr → ₹1,207 Cr
Cash conversion
0.85×·
Operating cash ÷ profit · 3 yrs
₹351 Cr on ₹415 Cr
Moves on a normal day
1.24%·
Median daily move
Last 267 sessions · the yardstick for filing-day moves
Where it sits among 29 Hospital peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#20/30
P/B#11/24
ROCE#16/30
ROE#17/24
Debt / Equity#9/24
EBITDA margin#10/24
Revenue growth#2/23
Profit growth#11/21

Scorecard

Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice

Strengths
Debt at 0.14× equity
lower than 65% of its 24 Hospital peers
Concerns
Nothing flagged in the filed numbers.

Charts

How has the market priced it — with filings on the timeline?

YATHARTH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from YATHARTH HOSP & TRA C S L's filed financials and exchange disclosures

What does YATHARTH HOSP & TRA C S L do?

YATHARTH HOSP & TRA C S L is a Healthcare Services company listed on NSE and BSE, trading under the symbol YATHARTH.

Is YATHARTH HOSP & TRA C S L profitable?

Yes. Over the trailing twelve months YATHARTH HOSP & TRA C S L reported a net profit of ₹174 Cr on revenue of ₹1,334 Cr.

Does YATHARTH HOSP & TRA C S L pay a dividend?

Not in the latest reported year — YATHARTH HOSP & TRA C S L's dividend payout for FY26 was nil.

Is YATHARTH HOSP & TRA C S L debt-free?

No. It reported borrowings of ₹253 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹32 Cr after cash. Debt stands at 0.14× equity. That is lower than 65% of its 24 Hospital peers.

Is YATHARTH HOSP & TRA C S L expensive compared with its peers?

On trailing P/E, YATHARTH HOSP & TRA C S L ranks 20 of 30 in Hospital — cheaper than 35% of them, against an industry median of 42.2×. This is a position, not a valuation judgement.

How much does the YATHARTH HOSP & TRA C S L share price move in a day?

On a typical session YATHARTH HOSP & TRA C S L moves 1.24% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.

When are YATHARTH HOSP & TRA C S L's next results?

Financial Results on Tue, 3 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track YATHARTH HOSP & TRA C S L's announcements?

Every NSE and BSE filing by YATHARTH HOSP & TRA C S L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.